The United States Food and Drug Administration (FDA) is aiming to give full approval for the Pfizer Covid-19 vaccine by early September, the New York Times reported on Tuesday (Aug 3), citing people involved in the effort.
The FDA gave emergency use authorization to the Pfizer vaccine late last year. Full approval by the FDA could push more Americans to get the Covid-19 vaccine as it might reduce their fears about the safety of the shot.
The agency’s unofficial deadline for the approval is the Sept 6 Labor Day holiday, the Times said. US President Joe Biden said last week he expected the FDA to make the decision by early fall.
Read the full article.
Breaking News: The FDA is now aiming to fully approve Pfizer-BioNTech’s coronavirus vaccine by the start of next month as a new surge of infections grows. https://t.co/u3PuUFISCh
— The New York Times (@nytimes) August 3, 2021